Intra-Cellular Therapies Statistics
Total Valuation
FRA:VIB3 has a market cap or net worth of EUR 462.40 million. The enterprise value is 974.90 million.
Market Cap | 462.40M |
Enterprise Value | 974.90M |
Important Dates
The next estimated earnings date is Thursday, October 23, 2025.
Earnings Date | Oct 23, 2025 |
Ex-Dividend Date | May 12, 2025 |
Share Statistics
Current Share Class | 12.61M |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 12.61M |
Valuation Ratios
The trailing PE ratio is 28.54 and the forward PE ratio is 31.46.
PE Ratio | 28.54 |
Forward PE | 31.46 |
PS Ratio | 0.31 |
PB Ratio | 1.35 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | 9.71 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.43, with an EV/FCF ratio of -107.13.
EV / Earnings | 60.18 |
EV / Sales | 0.65 |
EV / EBITDA | 7.43 |
EV / EBIT | 15.65 |
EV / FCF | -107.13 |
Financial Position
The company has a current ratio of 1.15, with a Debt / Equity ratio of 1.67.
Current Ratio | 1.15 |
Quick Ratio | 0.48 |
Debt / Equity | 1.67 |
Debt / EBITDA | 4.45 |
Debt / FCF | -62.97 |
Interest Coverage | 2.41 |
Financial Efficiency
Return on equity (ROE) is 4.69% and return on invested capital (ROIC) is 4.10%.
Return on Equity (ROE) | 4.69% |
Return on Assets (ROA) | 2.15% |
Return on Invested Capital (ROIC) | 4.10% |
Return on Capital Employed (ROCE) | 5.30% |
Revenue Per Employee | 123,405 |
Profits Per Employee | 1,333 |
Employee Count | 12,827 |
Asset Turnover | 0.86 |
Inventory Turnover | 2.59 |
Taxes
In the past 12 months, FRA:VIB3 has paid 12.60 million in taxes.
Income Tax | 12.60M |
Effective Tax Rate | 43.15% |
Stock Price Statistics
The stock price has decreased by -0.87% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -0.87% |
50-Day Moving Average | 17.42 |
200-Day Moving Average | 16.42 |
Relative Strength Index (RSI) | 38.08 |
Average Volume (20 Days) | 4,203 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:VIB3 had revenue of EUR 1.50 billion and earned 16.20 million in profits.
Revenue | 1.50B |
Gross Profit | 570.60M |
Operating Income | 59.80M |
Pretax Income | 29.20M |
Net Income | 16.20M |
EBITDA | 114.60M |
EBIT | 59.80M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 60.70 million in cash and 573.00 million in debt, giving a net cash position of -512.30 million.
Cash & Cash Equivalents | 60.70M |
Total Debt | 573.00M |
Net Cash | -512.30M |
Net Cash Per Share | n/a |
Equity (Book Value) | 343.60M |
Book Value Per Share | n/a |
Working Capital | 90.80M |
Cash Flow
In the last 12 months, operating cash flow was 47.60 million and capital expenditures -56.70 million, giving a free cash flow of -9.10 million.
Operating Cash Flow | 47.60M |
Capital Expenditures | -56.70M |
Free Cash Flow | -9.10M |
FCF Per Share | n/a |
Margins
Gross margin is 38.05%, with operating and profit margins of 3.99% and 1.08%.
Gross Margin | 38.05% |
Operating Margin | 3.99% |
Pretax Margin | 1.95% |
Profit Margin | 1.08% |
EBITDA Margin | 7.64% |
EBIT Margin | 3.99% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.90, which amounts to a dividend yield of 5.26%.
Dividend Per Share | 0.90 |
Dividend Yield | 5.26% |
Dividend Growth (YoY) | -14.29% |
Years of Dividend Growth | n/a |
Payout Ratio | 143.83% |
Buyback Yield | n/a |
Shareholder Yield | 5.26% |
Earnings Yield | 3.50% |
FCF Yield | -1.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on February 7, 2000. It was a forward split with a ratio of 10.
Last Split Date | Feb 7, 2000 |
Split Type | Forward |
Split Ratio | 10 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 5 |